ESR1 and neoplasm: Elevated levels of human HspB1 in ER-α positive benign neoplasia have been shown to promote the progression to more malignant phenotypes [16], increased anchorage independent tumor growth [17], increased resistance to chemotherapeutic drugs (including cisplatin and doxorubicin) and increased metastatic potential in vitro [18-20].